Skip to main content
. 2013 Mar 4;37(8):810–818. doi: 10.1111/apt.12270

Table 2.

Baseline characteristics and demographics by BMI*

NERD EO


BMI, kg/m2 BMI, kg/m2


<25 25 to <30 ≥30 <25 25 to <30 ≥30
Variable N = 267 N = 296 N = 363 N = 821 N = 1531 N = 1669
Gender, male, n (%) 61 (22.8) 115 (38.9) 89 (24.5) 443 (54.0) 941 (61.5) 774 (46.4)
Ethnicity, n (%)
 Not Hispanic or Latino 221 (82.8) 226 (76.4) 302 (83.2) 767 (93.4) 1400 (91.4) 1502 (90.0)
Race, n (%)
 American Indian/Alaskan Native 0 2 (0.7) 3 (0.8) 6 (0.7) 14 (0.9) 22 (1.3)
 Asian 9 (3.4) 6 (2.0) 1 (0.3) 90 (11.0) 66 (4.3) 16 (1.0)
 Black/African American 20 (7.5) 42 (14.2) 66 (18.2) 16 (1.9) 55 (3.6) 116 (7.0)
 Native Hawaiian/Pacific Islander 0 2 (0.7) 2 (0.6) 1 (0.1) 0 3 (0.2)
 Caucasian 234 (87.6) 238 (80.4) 283 (78.0) 692 (84.3) 1355 (88.5) 1451 (86.9)
 Multiracial 4 (1.5) 3 (1.0) 6 (1.7) 15 (1.8) 38 (2.5) 56 (3.4)
 Unknown 0 3 (1.0) 2 (0.6) 1 (0.1) 3 (0.2) 5 (0.3)
Age, years
 Mean ± s.d. 46.4 ± 15.10 48.9 ± 13.68 47.6 ± 12.92 44.9 ± 16.19 49.5 ± 13.40 47.3 ± 12.39
 Range 18–86 18–85 20–76 18–90 18–87 19–84
BMI, kg/m2
Mean ± s.d. 22.3 ± 1.86 27.4 ± 1.39 35.8 ± 5.87 22.6 ± 1.87 27.5 ± 1.41 35.4 ± 5.15
 Range 17–25 25–30 30–71 14–25 25–30 30–81
Alcohol drinker, n (%) 160 (59.9) 168 (56.8) 181 (49.9) 444 (54.1) 921 (60.2) 907 (54.4)
Smoker, n (%) 55 (20.6) 55 (18.6) 58 (16.0) 206 (25.1) 375 (24.5) 386 (23.1)
Caffeine user, n (%) 211 (79.0) 230 (77.7) 309 (85.1) 604 (73.6) 1202 (78.6) 1361 (81.6)
H. pylori status, n (%)
 Positive 68 (25.5) 102 (34.5) 101 (27.8) 14 (1.7) 18 (1.2) 30 (1.8)
 Negative 198 (74.2) 191 (64.5) 260 (71.6) 803 (97.8) 1507 (98.4) 1635 (98.0)
 Unknown 1 (0.4) 3 (1.0) 2 (0.6) 4 (0.5) 6 (0.4) 4 (0.2)
Baseline Los Angeles Grade of EO, n (%)
 A 368 (44.8) 537 (35.1) 511 (30.6)
 B N/A N/A N/A 271 (33.0) 547 (35.7) 623 (37.3)
 C 152 (18.5) 363 (23.7) 408 (24.4)
 D 30 (3.7) 84 (5.5) 127 (7.6)

BMI, body mass index; EO, erosive oesophagitis; N/A, not applicable; NERD, non-erosive gastro-oesophageal reflux disease; s.d., standard deviation.

*

All patients with evaluable diary data and heartburn symptom severity data at baseline and during treatment were included in this analysis.